Lyra Therapeutics (LYRA) Interest & Investment Income (2019 - 2025)
Lyra Therapeutics' Interest & Investment Income came in at $169,000 for Q4 2025, down 61.1% from $435,000 a year earlier and down 34.0% from the prior quarter.
Lyra Therapeutics (LYRA) Interest & Investment Income (2019 - 2025) Analysis & Trends
For FY2025, Lyra Therapeutics' Interest & Investment Income was $1.13 million, down 61.6% from FY2024.
- Interest & Investment Income carries a five-year compound annual growth rate of 69.1% (FY2020 to FY2025).
- Going back by year, Interest & Investment Income was $2.95 million in FY2024 (-34.4%), $4.5 million in FY2023 (+332.2%), $1.04 million in FY2022 (+920.6%) and $102,000 in FY2021 (+24.4%).
- The Q4 2025 figure represents the lowest quarterly Interest & Investment Income since Q3 2022.
- Year-over-year, Interest & Investment Income has declined for seven consecutive quarters, with an average decline of 45.5% over the last eight quarters.
- The fastest year-over-year change in Interest & Investment Income over five years came in Q2 2021 (growth of 420.0%), and the weakest in Q1 2025 (a decline of 72.6%).
- Business Quant data shows LYRA's Interest & Investment Income at $256,000 (Q3 2025), $410,000 (Q2 2025) and $298,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Lyra Therapeutics | 266,232.31 | 266,232.31 | - | 169,000.00 |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 169,000.00 |
| Sep 30, 2025 | 256,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Mar 31, 2025 | 298,000.00 |
| Dec 31, 2024 | 435,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Jun 30, 2024 | 855,000.00 |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 1.19 Mn |
| Jun 30, 2023 | 897,000.00 |
| Mar 31, 2023 | 1.07 Mn |
| Dec 31, 2022 | 933,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 34,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 26,000.00 |
| Mar 31, 2021 | 29,000.00 |
Lyra Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LYRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "LYRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LYRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();